The differentiation and proliferation of neural stem cells (NSCs) are regulated by a combination of their intrinsic properties (e.g., transcription factors, epigenetic factors, and microRNA regulation) and cell-extrinsic properties from the microenvironment around NSC (e.g., cytokines, growth factors, and cell-cell contact). Recently, there has been a great interest in clarifying the mechanism of the influence of the microenvironment on NSCs, especially cell-cell contact between NSCs and other types of cells nearby. In this study, we investigated whether microglial ( 
During brain development, neural stem cells (NSCs) are produced within germinal zones in close contact with the lateral ventricle walls. The self-renewal, proliferation, and differentiation of NSCs are regulated by the combination of their intrinsic properties (e.g., transcription factors, epigenetic factors, and microRNA regulation) and cell-extrinsic properties from the microenvironment around NSCs: the stem cell niche (e.g., cytokines, growth factors and cell-cell contact; ref. 1) . It is reasonable to believe that the interactions between precursor cells and the microenvironment faced by cells influence their differentiation. In accordance with this hypothesis, astrocytes influence the neuronal fate commitment of adult hippocampal NSCs (2), suggesting the importance of cell-cell interactions between glial cells and NSCs. In addition, recent studies (3, 4) have demonstrated that microglial cells play an important role in neurogenesis.
Microglial cells are hematopoietic in origin and have functions similar to those of other tissue macrophages, including phagocytosis, antigen presentation, and production of cytokines, chemokines, eicosanoids, complement components, matrix metalloproteinases, oxidative radicals, and nitric oxide (NO; ref. 5 ). In the normal brain, microglial cells display a quiescent phenotype. On insult to the brain, microglial cells became highly activated and express the products mentioned above. Activation of microglial cells can result in either neuroprotective or neurotoxic effects, or both. Even in the quiescent form, microglial cells can express and secrete several neurotrophic factors, as well as several cytokines and chemokines (6) .
Because microglial cells have been implicated in a variety of mechanisms of neuronal development and function (7), we investigated the effects of ramified microglial cells that secreted neither interleukin (IL) -6 nor NO on the fate of NSCs. Here, we demonstrated that ramified microglial cells promoted astrogliogenesis and maintenance of NSCs through activation of Stat3 function.
MATERIALS AND METHODS
All experiments were approved by the Ethics Committee of Ehime University Graduate School of Medicine and were conducted according to the Guidelines for Animal Experimentation at Ehime University Graduate School of Medicine.
Neurosphere generation and maintenance
NSCs were isolated from E-17 rats (Wistar rats; Charles River Laboratories, Inc., Yokohama, Japan). The meninges of embryonic rat brains were carefully cleared. The striatal tissue was separated from both hemispheres with fine forceps and was mechanically triturated. Cells were seeded in 9-cm dishes (Sumilon MS13900; Sumitoko Bakelite, Tokyo, Japan) in growth medium composed of Dulbecco modified Eagle medium (DMEM; Sigma Chemical, St. Louis, MO, USA) containing 0.2 mg/ml bovine serum albumin (A-7638, Sigma Chemical), 10 mM HEPES, 4.5 mg/ml glucose, 5 g/ml insulin, 5 nM sodium selenite, 5 g/ml transferrin, and 40 ng/ml human recombinant epidermal growth factor (Upstate Biotechnology, Lake Placid, NY, USA). Antibiotics and antimycotics (100 U/ml penicillin and 0.25 g/ml amphotericin B) were also included. NSCs were grown as neurospheres.
Microglial cell culture
The forebrains of newborn Wistar rats were dissected out, and cell suspensions were obtained by passing the tissues through a nylon mesh (160 m). The suspended cells were seeded in poly-l-lysine (mean M r 40,750; Sigma Chemical) -coated 80 cm 2 culture flasks (BD Biosciences, San Jose, CA, USA). They were cultured at 37°C in 5% CO 2 and nearly 100% humidity in DMEM supplemented with 10% fetal calf serum. The culture medium was changed every 2 days. Twelve to 14 days later, microglial cells were isolated according to the method of Suzumura et al. (8) with modification. In brief, microglial cells were detached from the astrocyte monolayers in the culture flasks by mechanical shaking and reseeded on 10-cm polystyrene dishes (Suspension Culture Dish; Corning, Corning, NY, USA). The cells were incubated for 10 min at 37°C, and then the dishes were washed twice with serum-free DMEM. The cells attached to the dishes were collected with a scraper and suspended in neurosphere-differentiating medium (Neurobasal medium: Invitrogen, Gaithersburg, MD, USA) containing B27 supplement (Invitrogen), all-trans-retinoic acid (1.0ϫ10 Ϫ7 M), 2 mM l-glutamine, and antibiotics (50 U/ml penicillin and 50 g/ml streptomycin). Some of the microglial cells were seeded onto 9-cm dishes (Sumilon MS13900, Sumitoko Bakelite) at a density of 1.4 ϫ 10 5 /ml or 4.0 ϫ 10 5 /ml and incubated in the same differentiating medium. Twenty-four hours later, the medium was collected, centrifuged for 15 min at 1500 rpm to remove debris, and used as microglia-conditioned medium (MCM).
Coculture of microglial cells with NSCs
Five days after seeding of triturated cells from the striatal tissue, they were dissociated mechanically and reseeded into poly-l-lysine-coated 24-well plates at a density of 5.0 ϫ 10 5 / well in neurosphere-differentiating medium (Neurobasal medium; Invitrogen) containing B27 supplement (Invitrogen), all-trans-retinoic acid (1.0ϫ10 Ϫ7 M), 2 mM l-glutamine, and antibiotics (50 U/ml penicillin and 50 g/ml streptomycin). Four hours later, after we confirmed that NSCs had attached to the bottom of the wells, three types of coculture of NSCs with microglial cells were prepared as follows:
Mixed type
Microglial cells (0, 0.7ϫ10 5 , or 2.0ϫ10 5 /well) were added directly to NSC cultures in a 24-well plate.
Insert type
Microglial cells (0, 0.7ϫ10 5 , or 2.0ϫ10 5 /well) were seeded into cell culture inserts (0.4 m pore size, BD Bioscience) that were placed on the top of a 24-well plate containing NSCs.
Conditioned type
Medium in a 24-well plate containing NSCs was changed to MCM (conditioned medium from 24 h microglia cultures based on neurosphere-differentiating medium at a density of 1.4ϫ10 5 /ml or 4.0ϫ10 5 /ml). The neurosphere-differentiating medium was changed every 2 days, and MCM was changed every day.
Adenoviral vectors
A recombinant adenovirus expressing human SOCS3 was constructed as described previously (9) . Human SOCS3 DNA was excised, and the resultant expression units were inserted at the SwaI site of the cosmid vector pAxCAwt (RBD:1678; Bio Resource Center, Riken, Wako, Japan). To make a dominantnegative form of murine Stat3 (Stat3F), the tyrosine residue at 705 of Stat3 was replaced with phenylalanine (Y705F; ref. 10). Stat3F DNA was excised, and the resultant expression units were inserted at the SwaI site of pAxCAwt. To generate recombinant adenoviruses (Ad.SOCS3 and Ad.Stat3F), cosmid DNA was cotransfected with the DNA-terminal protein complex into human kidney 293 cells. A recombinant adenovirus expressing ␤-galactosidase (Ad.Lz) was provided by Dr. Izumu Saito (University of Tokyo, Tokyo, Japan). Each recombinant virus was propagated in 293 cells and purified by CsCl step-gradient ultracentrifugation. Viral titers were determined using the modified end point cytopathic effect assay (11).
Application of inhibitors or adenoviral vectors
After growth medium was changed to neurosphere-differentiating medium or MCM, inhibitors or adenoviral vectors were applied to NSCs. The inhibitors used were as follows: LY294002 (CAS 154447-36-6; Promega, Madison, WI, USA) at 10 m/ml, Noggin (R&D Systems, Minneapolis, MN, USA) at 20 ng/ml, PTP inhibitor II (cat. 540205, CAS 2632-13-5; Calbiochem, La Jolla, CA, USA) at 0.1 nm/ml, and AG490 (cat. 658401; Calbiochem) at 1 m/ml. Our preliminary experiments revealed that inhibitors had no cytotoxic effects on NSCs at the concentrations used in this study, whereas they showed some cytotoxic effects on NSCs at 10ϫ higher concentrations (data not shown). Adenoviral vectors expressing SOCS3, Stat3F, or Lz [multiplicity of infection (MOI) ϭ10] were also applied to NSCs. For quantitative real-time polymerase chain reaction (PCR) and Western blot analysis, cells were collected at 1 or 3 days after the application of inhibitors or adenoviral vectors.
Immunoblot analysis
Cells were solubilized in Laemmli's lysis buffer containing 2% sodium dodecyl sulfate (12) . The suspension was resolved by electrophoresis, transferred to nitrocellulose sheets, and immunoblotted using a rabbit polyclonal antibody against glial fibrillary acidic protein (GFAP; G9269; Sigma) or mouse monoclonal antibodies against ␤-actin (A5441; Sigma), Stat3 (sc-8019; Santa Cruz Biotechnology, Santa Cruz, CA, USA), pStat3 (Tyr705-phosphorylated Stat3; sc-8059; Santa Cruz Biotechnology), SOCS3 (sc-9023; Santa Cruz Biotechnology), microtubule-associated protein 2 (MAP2; Sternberger Monoclonals, Lutherville, MD, USA), Tuj1 (MMS-435P; Covance Research, Berkeley, CA, USA), and Nestin (MAB353; Chemicon, Temecula, CA, USA) proteins. The second antibodies were alkaline phosphatase-conjugated anti-rabbit immunoglobulin G (IgG) for the rabbit polyclonal antibody or alkaline phosphatase-conjugated anti-mouse IgG for the mouse monoclonal antibodies. The density of immunoreac-tive bands was measured using NIH image software (National Institutes of Health, Bethesda, MD, USA).
Luciferase promoter assay
The constructs of the Stat3 reporter plasmids have been described elsewhere (9) . In brief, the Stat3F reporter plasmid contained 4 copies of the acute-phase response element (APRE) in front of the minimal junB promoter linked to the luciferase gene. The response element was the APRE of the rat ␣2-macroglobulin gene (5Ј-GCGCCTTCTGGGAAGATC-CTTACGGGAATTCAG-3Ј). The cultured neurospheres were washed once in PBS, triturated, and resuspended in the specified electroporation buffer to a final concentration of 1.0 ϫ 10 7 cells/ml. Then, 10 g Stat3 reporter plasmid and 4 g pRL-TK (Promega) internal control plasmid DNA were mixed with 0.1 ml cell suspension, transferred to a 2.0-mm electroporation cuvette, and electroporated with an Amaxa Nucleofector apparatus (Amaxa, Cologne, Germany). Then transfected neurospheres were exposed to adenoviral vectors expressing SOC3, Stat3F, or Lz (MOIϭ10) for 1 h in differentiating medium or MCM. Some transfected neurospheres were treated with both mouse leukemia inhibitory factor (LIF; 30 ng/ml; Chemicon, Temecula, CA, USA) and human basic fibroblast growth factor (bFGF; 10 ng/ml; Genzyme Techne, Minneapolis, MN, USA) or both rat IL-6 (30 ng/ml; Peprotech, London, UK) and human sIL-6R (30 ng/ml, Peprotech) as a positive control. Two days after electroporation, the activity of firefly luciferase from the Stat3 promoterluciferase plasmid and renilla luciferase from the pRL-TK plasmid in the cell extracts was evaluated using a dualluciferase assay kit (Promega) with a luminometer (TD-20/ 20; Turner Designs, Sunnyvale, CA, USA). Relative firefly luciferase activity was calculated by normalizing the transfection efficiency according to the renilla luciferase activity.
Quantitative real-time PCR
Cells were washed with PBS, and total RNA was extracted using Isogen (Nippon Gene, Tokyo, Japan). Total RNA was digested with DNase, and then single-stranded cDNA was obtained using oligo dT primers and Moloney murine leukemia virus reverse transcriptase (Life Technologies, Rockville, MD, USA). For quantitative real-time PCR, TaqMan real-time PCR analysis was carried out. The oligonucleotide primers and TaqMan fluorogenic probe for each gene were purchased commercially (Applied Biosystems, Foster City, CA, USA; Table 1 ). Reactions were run on an ABI Prism 7700 sequence detection system (Applied Biosystems). The cycling conditions were 10 min polymerase activation at 95°C followed by 40 cycles at 95°C for 15 s and 60°C for 60 s. ␤-Actin was used as the internal control. Threshold cycle (Ct) values of the target genes were normalized to those of the internal control genes. The relative expression in each sample to that of the control sample was calculated according to the 2Ϫ⌬⌬CT method (13) .
Immunocytochemistry
Cells were washed with PBS and fixed for 30 min with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). After 3 washes with PBS, the samples were incubated with 10% normal goat serum dissolved in PBS. Either a primary mouse monoclonal antibody against MAP2 (Sternberger Monoclonals) or a rabbit polyclonal antibody against GFAP (Sigma) was incubated with the samples at 4°C overnight. The samples were washed 3 times with PBS, incubated with rhodamineconjugated goat anti-mouse IgG (ICN, Irvine, CA, USA) or with fluorescein-5-isothiocyanate-conjugated goat anti-rabbit IgG (ICN) for 30 min at room temperature, washed 3 times with PBS and mounted in Vectashield (Vector Lab, Burlingame, CA, USA). The cells were counterstained with Hoechst 33342 (B2261; Sigma) to identify nuclei.
Enzyme-linked immunosorbent assay (ELISA) and NO assay
Microglial cells at a density of 4.0 ϫ 10 5 /ml were cultured for 24 h in neurosphere-differentiating medium. After their settlement was confirmed, cells were cultured with fresh neurosphere-differentiating media in the presence and absence of lipopolysaccharide (LPS; 1 g/ml). One day later, the supernatants were collected and the assays were per- Leukemia inhibitory factor (LIF) Rn00755092_m1
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formed. The concentrations of IL-1␤, IL-6, and tumor necrosis factor (TNF) -␣ in the supernatants were measured by ELISA. The nitrite levels were determined after mixing equal amounts of supernatant and Griess reagent [N-(1-naphthyl)-ethylenediamine (0.1%) and sulfanilamide (1%)] (Sigma). ELISA kits were purchased from BioSource USA (Camarillo, CA, USA) and used according to the manufacturer's protocol. Sodium nitrite (Sigma) was used as a standard solution.
Statistical analysis
All values are presented as means Ϯ sd. The levels of nitrite and cytokines in the presence and absence of LPS were analyzed statistically by unpaired t test. All the other statistical significances were tested by one-way ANOVA followed by Bonferroni's multiple comparison test. A value of P Ͻ 0.05 was considered statistically significant.
RESULTS

Coculture with microglial cells promotes astrogliagenesis in NSCs
We first examined whether coculture of NSCs with microglial cells could modulate the differentiation of NSCs. To address this issue, microglial cells (0, 0.7ϫ10 5 , or 2.0ϫ10 5 /well) were directly added to NSC culture (5.0ϫ10 5 /well) in 24-well plates (mixed type). At 3 days after coculture, cells were homogenized in lysis buffer and immunoblotted with an antibody against GFAP (a specific marker of astrocytes) or MAP2 (a specific marker of neurons). Experiments were carried out 5 times independently. Densitometric analysis revealed that 3 days after coculture, the level of GFAP protein in NSCs with microglial cells (0.7ϫ10 5 and 2.0ϫ10 5 /well) was significantly increased (ϳ1.7-and 1.7-fold, respectively) compared with that in the control without microglial cells, whereas the level of MAP2 protein did not differ among the three groups (Fig. 1A-C) .
To prevent physical interactions between NSCs and microglial cells, we performed another type of coculture in which the two cell populations were cultured in the same well, but were separated by a culture insert membrane that permitted medium exchange without physical contact between NSCs and microglial cells (insert type). Microglial cells (0, 0.7ϫ10 5 , or 2.0ϫ10 5 /well) were seeded into cell culture inserts that were placed on the top of a 24-well plate containing neurospheres. Three days after coculture, the level of GFAP protein in neurospheres with microglial cells was significantly increased (ϳ2.0-and 2.2-fold) compared with that in the control without microglial cells, whereas the level of MAP2 protein did not differ among the three groups (Fig. 1D-F) .
Because coculture study using culture inserts suggested that the effect of microglial cells on NSC differentiation was related to diffusible factors released by microglial cells in the medium, we next investigated the effects of MCM on the fate of NSCs. Medium in a 24-well plate containing neurospheres was changed to the conditioned medium from 24 h microglia cultures at a density of 0, 1.4 ϫ 10 5 /ml, or 4.0 ϫ 10 5 /ml (conditioned type). Three days after culture with MCM, the level of GFAP protein in NSCs cultured with MCM (1.4ϫ10 5 /ml and 4.0ϫ10 5 /ml) was significantly increased (ϳ1.8-and 1.7-fold) compared with that in the control without MCM, whereas the level of MAP2 protein did not differ among the three groups ( Fig.  1G-I ).
Taken together, these results showed that microglial cells promoted astrogliogenesis in NSCs and that this microglia-induced astrogliogenesis was not related to physical contact between the two cell populations but to some diffusible factors released by microglial cells. Hence, thereafter, we investigated the mechanisms of microglia-induced astrogliogenesis by using MCM (conditioned type).
AG490 inhibits microglia-induced astrogliogenesis in NSCs, whereas LY29002, PTPII, and Noggin do not
To clarify the mechanism of microglia-induced astrogliogenesis in NSCs, we applied reagents to inhibit the cell signaling for modulating the fate of NSCs. After NSCs were seeded into 24-well plates at a density of 5.0 ϫ 10 5 /well, they were incubated with MCM (conditioned medium from 24 h microglia cultures at a density of 1.4ϫ10 5 /ml) in the presence and absence of these inhibitors. One or 3 days later, the cells were homogenized in lysis buffer and immunoblotted with antibodies against GFAP or MAP2. Experiments were carried out 5 times independently. Densitometric analysis revealed that a phosphoinositide 3-kinase (PI3K) inhibitor (10 m/ml LY294002) did not inhibit microglia-induced astrogliogenesis (Fig. 2) . Furthermore, a BMP-specific antagonist (20 ng/ml Noggin) and an SHP (Src homology 2 domain-containing tyrosine phosphatase) inhibitor (0.1 nm/ml PTP inhibitor II) did not inhibit this astrogliogenesis (Figs. 3 and 4) . However, a Jak2 kinase inhibitor (1 m/ml AG490) inhibited microglia-induced astrogliogenesis in NSCs (Fig. 5) . Three days after incubation, the level of GFAP protein in NSCs with MCM was significantly increased (1.8-fold) compared with that in NSCs without MCM. With the addition of AG490, the level of GFAP protein was reduced to the control level (Fig. 5F ). These results showed that the Jak/Stat signaling pathway played a crucial role in astrogliogenesis of NSCs mediated by microglial cells.
To confirm whether the increase of GFAP is really due to the increase of the number of astrocytes, we performed immunostaining for counting cell numbers. After NSCs were seeded into 24-well plates at a density of 2.0 ϫ 10 5 /well, they were incubated with neurosphere-differentiating medium or MCM in the presence or absence of AG490 (1 m/ml). Three days later, expression of differentiation markers was evaluated by immunostaining with antibodies against GFAP and MAP2. Cells that were positive for MAP2 or GFAP were scored in 10 to 15 random nonoverlapping fields (400 m 2 ) in each experiment. The proportion of MAP2 
Stat3F and SOCS3 inhibit microglia-induced astrogliogenesis in NSCs
It is well known that Stat3 plays crucial roles in determining the fate of NSCs. Enhancement of Stat3 activity in NSCs leads to subsequent glial differentiation (14) . Our inhibitor study showed that AG490, a Jak2 kinase inhibitor, suppressed microglia-induced astrogliogenesis, suggesting that the Jak/Stat signaling pathway, especially activation of Stat3 function, played a crucial role in microglia-induced astrogliogenesis in NSCs. To confirm this assumption, we used two types of adenovirus vectors expressing Stat3F and SOCS3. Stat3F is a dominant-negative form of Stat3. In this mutant (Stat3F), the tyrosine residue at amino acid position 705 of murine Stat3 is mutated to phenylalanine. Stat3F binds to the gp130 receptor, which in turn leads to competitive inhibition of phosphorylation of endogenous Stat3 on activation of the gp130 receptor. When expressed at high levels, Stat3F has been shown to block activation of endogenous Stat3 in various types of cells including NSCs (10) . SOCS3 has been shown to interact with gp130 and Jak, and this interaction results in relatively specific inhibition of gp130 signaling (15) . Moreover, SOCS3 has been shown to block activation of endogenous Stat3 in NSCs (9) .
By using these two types of adenovirus vectors, we examined whether microglia-induced astrogliogenesis was inhibited by blocking the activation of endogenous Stat3 in NSCs. After NSCs were seeded into 24-well plates at a density of 5.0 ϫ 10 5 /well, they were inoculated with an adenovirus vector expressing Stat3F, /well, NSCs were incubated with MCM in the presence and absence of a PTP inhibitor II (0.1 nm/ml PTPII; an SHP inhibitor). One day (A-C) or 3 days later (D-F), the cells were homogenized in lysis buffer and immunoblotted with antibodies against GFAP or MAP2. Experiments were carried out 5 times independently. Note that the protein levels of GFAP and MAP2 did not differ irrespective of the presence of PTP inhibitor II. **P Ͻ 0.01 vs. NS only.
SOCS3, or LacZ (10 MOI each) and incubated with MCM (conditioned medium from 24 h microglia cultures at a density of 1.4ϫ10 5 /ml). Three days later, the cells were homogenized in lysis buffer and immunoblotted with an antibody against ␤-actin, SOCS3, Stat3, or pStat3 (Tyr705-phosphorylated Stat3).
Western blot analysis revealed that strong Stat3 and SOCS3 expression was evident in Ad.Stat3F-and Ad.SOCS3-infected cells but not in Ad.Lz-infected cells at 3 days after infection (Fig. 7A) . Stat3 protein was expressed in both Ad.Lz-and Ad.SOCS3-infected cells. Moreover, pStat3 was weakly expressed in Ad.Lz-infected cells, but expression of pStat3 was not evident in Ad.Stat3F-and Ad.SOCS3-infected cells (Fig. 7A) . These data suggest that overexpression of Stat3F and SOCS3 could suppress Stat3 cell signaling in NSCs.
We next examined whether overexpression of Stat3F and SOCS3 could modulate the differentiation of NSCs. At 3 days after infection, cells were homogenized in lysis buffer and immunoblotted with an antibody against GFAP, MAP2, or Nestin (a marker of NSCs). Experiments were carried out 5 times independently.
Densitometric analysis revealed that 3 days after infection, MCM significantly increased the level of GFAP protein in Ad.LacZ-infected cells (ϳ3.4-fold), whereas the level of MAP2 protein did not differ among all groups (Fig. 7B, C) . Furthermore, the level of GFAP protein in Ad.Stat3F-and Ad.SOCS3-infected cells cultured with MCM was significantly reduced (ϳ1.7-and 5.2-fold, respectively), compared with that in Ad.Lzinfected cells cultured with MCM (Fig. 7B) . These results suggested that microglia-induced astrogliogenesis was inhibited by blocking the activation of endogenous Stat3 in NSCs.
In addition, densitometric analysis revealed that 3 days after infection, MCM significantly increased the level of Nestin protein in Ad.LacZ-infected cells (ϳ1.4-fold; Fig. 7D ). Furthermore, compared with that in Ad.Lz-infected cells cultured without MCM, the level of Nestin protein in Ad.SOCS3-infected cells cultured with MCM increased further (ϳ1.6-fold; Fig. 7D ). These results suggested that MCM promoted the maintenance of NSCs and SOCS3 accelerated this action.
Ramified microglial cells release neither NO nor inflammatory cytokines
To specify the properties of the microglial cells, we evaluated the amounts of NO and cytokines [interleukin (IL)-1␤, IL-6, and TNF-␣]. As shown in Fig. 8B-E , microglial cells in neurosphere-differentiating medium without LPS released little amounts of NO and inflammatory cytokines. Moreover, the shape of these microglial cells was a ramified form (Fig. 8A) .
Real-time PCR for trophic factors in neurons, astrocytes, microglial cells, and NSCs
Because microglia-induced astrogliogenesis in NSCs appeared to occur through paracrine effects, we next investigated mRNA levels of several secreted trophic factors that are considered to modulate the fate of NSCs. We compared mRNA levels of several trophic factors among neurons, astrocytes, microglial cells, and NSCs by realtime PCR. Data were obtained from 4 independent experiments. Among the trophic factors examined, the expression of LIF and FGF2 mRNA in microglial cells was markedly upregulated (ϳ78.0-and 28.4-fold increase, respectively), compared with those in NSCs (Fig. 9) . Furthermore, microglial cells did not express IL-6, CT1, BMP4, and EGF mRNA in our experimental conditions. These results suggested that LIF and FGF2 were involved in the mechanism of microglia-induced astrogliogenesis in NSCs and that microglial cells were not activated in our experimental conditions.
Promoter assay with and without MCM
To confirm whether MCM could actually activate Stat3 function in NSCs, minimal junB reporter constructs with or without 4 copies of APRE were electroporated into the neurospheres. Then, the neurospheres were exposed to adenoviral vectors expressing SOCS3, Stat3F, or LacZ in the presence and absence of MCM. Two days later, dual luciferase assay was carried out. Experiments were carried out 5 times independently. After transfection of the Stat3 reporter plasmid (minimal junB promoter with 4 copies of APRE), relative luciferase activity in Ad.LacZ-, Ad.Stat3F-, Ad SOCS3-and Ad.LacZ ϩ LIF ϩ FGF2-treated NSCs cultured with MCM was significantly increased (ϳ35.9-, 2.4-, 3.0-, and 2.0-fold, respectively) compared to that in Ad.LacZ-, Ad.Stat3F-, Ad.SOCS3-, and Ad.LacZ ϩ LIF ϩ FGF2-treated NSCs cultured without MCM, respectively (Fig.  10A) . When NSCs were cultured without MCM, relative luciferase activity of Ad.Stat3F-and Ad.SOCS3-treated NSCs was significantly lower (ϳ1.7-and 1.8-fold, respectively) than that of Ad.LacZ-treated NSCs, whereas relative luciferase activity of Ad.LacZ ϩ LIF ϩ FGF2-treated NSCs was significantly higher than that of Ad-.LacZ-treated NSCs. When NSCs were cultured with MCM, the relative luciferase activity of Ad.Stat3F-and Ad.SOCS3-treated NSCs was significantly lower (ϳ26.1-and 21.9-fold reduction, respectively) than that of Ad.LacZ-treated NSCs (Fig. 10A) . However, after transfection of Stat3 control plasmid (minimal junB promoter without 4 copies of APRE), the relative luciferase activity did not differ among all groups (Fig.  10B) . Taken together, these results proved that MCM, as well as treatment with LIF ϩ FGF2, transactivated APRE and promoted Stat3 function. We also confirmed that overexpression of Stat3F and SOCS3 inhibited APRE transactivation via MCM and blocked Stat3 function.
Real-time PCR for Notch family members and inhibitory basic helix-loop-helix (bHLH) factors
Notch family members and inhibitory bHLH transcription factors play an important role in proliferation, cell lineage determination, and cell differentiation of NSCs (16) . We therefore examined the effects of MCM on the mRNA levels of Notch family members (notch1, 2, and 3) as well as inhibitory bHLH transcription factors (hes1, hes5, id1, id2, and id3) in NSCs in the presence or absence of AG490. The mRNA levels in NSCs were evaluated using real-time PCR at 1 day after culture with MCM. Data were obtained from 4 independent experiments.
One day after culture with MCM, the mRNA levels of notch1-3, hes5, and id3 in NSCs were significantly increased (ϳ3.4-, 1.8-, 2.5-, 1.4-, and 4.7-fold, respectively), compared with those in NSCs without MCM (Fig. 11A) . Furthermore, after treatment with AG490, the mRNA levels of notch1, 2, and 3 in NSCs were significantly decreased (ϳ1.6-, 1.5-, and 1.4-fold, respectively), whereas the mRNA level of hes5 was significantly increased further (ϳ1.4-fold). Irrespective of treatment with AG490, the mRNA level of id3 in NSCs cultured with MCM was not changed.
Real-time PCR for proneural bHLH factors and Sox9 in NSCs
Proneural bHLH factors have been reported to block astrocyte differentiation (17) , and in their absence, neural progenitors become astrocytes (18) . On the contrary, Sox9 plays a crucial role in causing NSCs to switch from neurogenesis to gliogenesis (19) . For these Figure 9 . Expression of trophic factors in neurons, astrocytes, microglial cells, and NSCs. Cultured neurons, astrocytes, microglial cells, and NSCs were washed with PBS, and total RNA was extracted using Isogen (Nippon Gene). Total RNA was digested with DNase, and then single stranded cDNA was obtained using oligo dT primers and Moloney murine leukemia virus reverse transcriptase (Life Technologies). For quantitative real-time PCR, TaqMan real-time PCR analysis was carried out. The oligonucleotide primers and TaqMan fluorogenic probe for each gene were purchased commercially (Applied Biosystems; Table 1 ). The mRNA levels of several trophic factors were compared among neurons, astrocytes, microglial cells, and NSCs by real-time PCR. Data were obtained from 4 independent experiments. Note that expression of LIF and FGF2 in microglial cells was significantly upregulated, compared with that in NSCs. **P Ͻ 0.01 vs. NSC;
# not detected.
reasons, we examined the effects of MCM on the mRNA levels of proneural bHLH factors (mash1, neuroD1, and neuroD2) and sox9 in NSCs. One day after culture with MCM, mRNA levels of mash1, neuroD1, and neuroD2 were significantly decreased in NSCs (ϳ1.9-, 1.4-, and 1.6-fold, respectively), whereas the mRNA level of Sox9 was significantly increased in NSCs (ϳ1.3-fold; Fig. 11B ). Treatment with AG490 significantly decreased mRNA levels of neuroD2 and sox9 (ϳ1.6-and 2.0-fold, respectively) in NSCs cultured with MCM.
DISCUSSION
In the present study, we prepared three types of coculture of NSCs with microglial cells: mixed type, insert type, and conditioned type. In all types, microglial cells promoted astrogliogenesis, suggesting that their effects were not caused by physical contact between the two cell populations but by some diffusible factors released by microglial cells. Our results differed from previous reports (20, 21) that microglial cells promoted neurogenesis in adult NSCs. One possible explanation is the difference in NSCs (i.e., embryonic NSCs from the ganglionic eminences were used in our study whereas adult NSCs from the subventricular zone or the hippocampus were used in their studies). Another possible explanation is that the condition of microglial cells was different. It has been reported that both interferon-␥-and IL-4-activated microglial cells promoted neurogenesis of adult NSCs whereas LPS-activated microglial cells inhibited this neurogenesis (22) . Moreover, macrophage colony-stimulating factor (M-CSF) -activated microglial cells promoted astrogliogenesis of NSCs (23) . In our study, microglial cells were not activated by cytokines (such as interferon-␥ and IL-4) or LPS. Consequently, IL-6 mRNA was not detected in microglial cells and little amounts of NO and inflammatory cytokines, such as IL-1␤, IL-6, and TNF-␣ were detected in the conditioned medium. Furthermore, these microglia cells were displaying a ramified morphology. Thus, we demonstrated that ramified microglial cells promoted astrogliogenesis through their paracrine effects.
To investigate the cell signaling pathways of this microglia-induced astrogliogenesis of NSCs, we applied four types of reagents to inhibit the cell signaling for modulating the fate of NSCs. Consequently, a PI3K inhibitor (LY294002), a BMP-specific antagonist (Noggin), and an SHP inhibitor (PTP inhibitor II) did not inhibit this astrogliogenesis. Among them, only the Jak2 kinase inhibitor (AG490) inhibited microglia-induced astrogliogenesis in NSCs, suggesting a crucial role of the Jak-Stat signaling pathway in this mechanism. Subsequent studies, using adenovirus vectors, revealed that Stat3 (especially gp130 signaling) played a pivotal role in microglia-induced astrogliogenesis of NSCs. It is well known that Stat3 plays crucial roles in determining the fate of NSCs. Enhancement of Stat3 activity in NSCs leads to subsequent glial differentiation (14) . LIF as well as ciliary neurotrophic factor (CNTF) and IL-6 can activate the Jak-Stat signaling pathway and promote astroglial differentiation (24) . Phosphorylated Stat3 associates with the transcriptional coactivators CREB-binding protein (CBP/p300) to activate expression of astrocyte-specific genes (25) . DNA methylation is also a critical determinant in the developmental stage-dependent regulation of astrocytogeneis (26) . In this study, we showed that the level of LIF mRNA in microglial cells was significantly higher than that in NSCs, although the level of CNTF mRNA in microglial cells was significantly lower than that in NSCs, and neither IL-6 mRNA nor CT1 mRNA was detected in microglial cells. These data suggested that ramified microglial cells secreted LIF and promoted astrogliogenesis in NSCs. We also showed that the level of FGF2 mRNA in microglial cells was significantly greater than that in NSCs. FGF2 was first purified as a heparin-binding polypeptide from bovine pituitary and was subsequently characterized as a basic protein of 18 kDa (27) . FGF-2 is a strong promoter of fibroblast proliferation. However, most of the interest in FGF-2 stems from its pleiotropic effects. FGF-2 is one of the most potent angiogenic factors, possesses neuroprotective properties, and is implicated in vascular remodeling and tumor metastasis (28) . It has been shown that the in vitro expansion and differentiation of NSCs can be regulated by adding FGF2 to the culture medium (29) . Moreover, it has been reported that FGF2 is expressed in the dorsolateral cortical neuroepithelium of the forebrain and FGF2 is one of the most potent mitogens and survival factors for cultured NSCs (30) . As well as FGF-2, LIF is also known to be required for long-term maintenance of NSCs (31) . In our study, we demonstrated that the level of Nestin protein in NSCs was significantly increased by treatment with MCM, suggesting that ramified microglia-derived LIF and FGF2 promoted the maintenance of NSCs.
To clarify the molecular mechanisms underlying microglia-induced astrogliogenesis, we investigated the expression of Notch family members bHLH transcription factors, and sox9 genes. Notch family members and bHLH transcription factors play important roles in proliferation, cell lineage determination and cell differentiation of NSCs (16) . Several investigators have shown interactions between the Stat3 and Notch pathways. It has been reported that activation of glycoprotein 130 (gp130; a common receptor component of IL-6 family cytokines) stimulates the Notch1 pathway, increasing the expression of hairy-enhancer-of-split 1 (Hes1; ref. 32) . It has also been demonstrated that Stat3 is an essential effector of Notch-Hes signaling (33) . Furthermore, it has been reported that the notch ligand delta-like 1 (DLL1) is a key target of Stat3 in both inhibition of neurogenesis and maintenance of NSCs, which may underlie the noncell-autonomous action of Stat3 in inhibiting neuronal differentiation (34) . In this study, we showed significant up-regulation of notch 1, 2, and 3 mRNA at 1 day after treatment with MCM, and this up-regulation was significantly inhibited by the Jak2 inhibitor, AG490, whereas hes1 and hes5 mRNA were not. We cannot explain why the temporal profiles of hes1 and hes5 mRNA (downstream genes of notch signaling) were not the same as those of notch1-3 mRNA. However, neurospheres could be generated from embryos mutant for hes1 and hes5. Hes1 and hes5 double-mutant neurospheres still demonstrated self-renewal (35) . It has also been reported that neither hes1 nor hes5 mediates gp-130-enhanced notch signaling that regulates NSC maintenance (32) . These results support the contention that besides the Notch-Hes pathway other signaling pathways can mediate notch signaling in the maintenance and differentiation of NSCs.
In addition, it is well known that Sox9 plays a crucial role in chondrocyte development and male sex determination (36) . Recently, it has been demonstrated that Sox9 is essential for proper development of both oligodendrocytes and astrocytes and suggested that Sox9 is a component of the mechanism that causes NSCs to switch from neurogenesis to gliogenesis (19) . Sox9 has also been implicated in maintaining cells in a stem cell-like state and preventing their exit from the cell cycle and the induction of neurogenesis (37) . Furthermore, notch signaling is required for the maintenance of Sox9 expression during the gliogenic phase of spinal cord development (38) . Consistent with these previous reports, our data showed that MCM-induced up-regulation of sox9 and notch1-3 promotes astrogliogenesis and maintenance of NSCs.
In conclusion, we have demonstrated that ramified Figure 11 . mRNA expression profiles of notch family, bHLH factors, or sox9 after 1 day of treatment with MCM in the presence or absence of AG490. After NSCs were seeded into 24-well plates at a density of 5.0 ϫ 10 5 /well, NSCs were incubated with MCM in the presence and absence of AG490 (a Jak2 kinase inhibitor; 1 m/ml). As a control, NSCs were incubated only with neurosphere-differentiating medium (mock). One day later, total RNA was extracted using Isogen (Nippon Gene). Total RNA was digested with DNase, and then single-stranded cDNA was obtained using oligo dT primers and Moloney murine leukemia virus reverse transcriptase (Life Technologies). For quantitative real-time PCR, TaqMan real-time PCR analysis was carried out. The oligonucleotide primers and TaqMan fluorogenic probe for each gene were purchased commercially (Applied Biosystems; Table 1 ). Data were obtained from 4 independent experiments. Note that expression of notch1-3 (A) and sox9 (B) was significantly upregulated after treatment with MCM, and this up-regulation was significantly inhibited by AG490. *P Ͻ 0.05, **P Ͻ 0.01 vs. Mock; & P Ͻ 0.05, && P Ͻ 0.01 vs. MCM.
microglial cells promote astrogliogenesis and maintenance of NSCs through their paracrine effects and that their effects are caused by activation of Stat3 function. This finding of active roles of microglial cells is unexpected and raises the possibility that neuronal production in the brain is regulated, at least in part, by the regional properties of microglial cells.
